Helen Yvette Barnett

7PUBLICATIONS
3CO-AUTHORS
Radiation therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 05, 2025
Joint time-to-event partial order continual reassessment method and Joint time-to-event Bayesian logistic regression model: Statistical designs for dual agent phase I/II dose finding studies with late-onset toxicity and activity outcomes.

Helen Barnett, Oliver Boix, Dimitris Kontos

|Oct 14, 2024
A seamless Phase I/II platform design with a time-to-event efficacy endpoint for potential COVID-19 therapies.

Thomas Jaki, Helen Barnett, Andrew Titman

|Jan 24, 2024
A comparison of model-free phase I dose escalation designs for dual-agent combination therapies.

Helen Barnett, Matthew George, Donia Skanji

|Mar 23, 2023
Backfilling cohorts in phase I dose-escalation studies.

Helen Barnett, Oliver Boix, Dimitris Kontos

|Oct 17, 2022
Dose finding studies for therapies with late-onset toxicities: A comparison study of designs.

Helen Barnett, Oliver Boix, Dimitris Kontos

|Oct 20, 2021
A novel statistical test for treatment differences in clinical trials using a response-adaptive forward-looking Gittins Index Rule.

Helen Yvette Barnett, Sofía S Villar, Helena Geys

Pageof 2

Frequent Collaborators

5 joint publications

Thomas Jaki

2 joint publications

Pavel Mozgunov

1 joint publications

Sofía S Villar